title: Fetomaternal alloimmune thrombocytopenia: the questions that still remain.
abstract: Fetomaternal alloimmune thrombocytopenia (FMAIT) occurs when maternal antibodies are formed to fetal platelet antigens, leading to thrombocytopenia and hemorrhagic complications. The diagnosis is frequently made only after a major hemorrhagic event has occurred during a pregnancy. Identifying patients at risk remains difficult, and the optimal treatment regimen remains to be determined.
authors: Division of Maternal Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD 21287, USA. jalthau1@jhmi.edu
authors: Janyne
authors: J
authors: Althaus
authors: Karin J
authors: KJ
authors: Blakemore
mesh_terms: D005260:Female; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000628:therapy*; D011296:Prenatal Diagnosis / Q000379:methods; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D013997:Time Factors